Mladinska knjiga Zalozba, d. d. (LJSE:MKZG)

Verve Therapeutics Statistics

Total Valuation

LJSE:MKZG has a market cap or net worth of EUR 7.39 million. The enterprise value is 9.28 million.

Market Cap	7.39M
Enterprise Value	9.28M

Important Dates

The last earnings date was Wednesday, June 4, 2025.

Earnings Date	Jun 4, 2025
Ex-Dividend Date	n/a

Share Statistics

LJSE:MKZG has 1.19 million shares outstanding.

Current Share Class	1.19M
Shares Outstanding	1.19M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	163,154

Valuation Ratios

The trailing PE ratio is 6.33.

PE Ratio	6.33
Forward PE	n/a
PS Ratio	0.10
PB Ratio	0.18
P/TBV Ratio	0.20
P/FCF Ratio	1.46
P/OCF Ratio	1.27
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 1.99, with an EV/FCF ratio of 1.83.

EV / Earnings	7.95
EV / Sales	0.12
EV / EBITDA	1.99
EV / EBIT	5.32
EV / FCF	1.83

Financial Position

The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.19.

Current Ratio	1.82
Quick Ratio	0.90
Debt / Equity	0.19
Debt / EBITDA	1.63
Debt / FCF	1.50
Interest Coverage	4.94

Financial Efficiency

Return on equity (ROE) is 2.87% and return on invested capital (ROIC) is 2.23%.

Return on Equity (ROE)	2.87%
Return on Assets (ROA)	1.62%
Return on Invested Capital (ROIC)	2.23%
Return on Capital Employed (ROCE)	3.53%
Revenue Per Employee	119,077
Profits Per Employee	1,787
Employee Count	653
Asset Turnover	1.16
Inventory Turnover	4.73

Taxes

In the past 12 months, LJSE:MKZG has paid 202,588 in taxes.

Income Tax	202,588
Effective Tax Rate	14.79%

Stock Price Statistics

The stock price has increased by +55.00% in the last 52 weeks. The beta is -1.41, so LJSE:MKZG's price volatility has been lower than the market average.

Beta (5Y)	-1.41
52-Week Price Change	+55.00%
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	78.28
Average Volume (20 Days)	574

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LJSE:MKZG had revenue of EUR 77.76 million and earned 1.17 million in profits. Earnings per share was 0.98.

Revenue	77.76M
Gross Profit	5.80M
Operating Income	1.74M
Pretax Income	1.37M
Net Income	1.17M
EBITDA	2.67M
EBIT	1.74M
Earnings Per Share (EPS)	0.98

Balance Sheet

The company has 7.66 million in cash and 7.60 million in debt, giving a net cash position of 65,272 or 0.05 per share.

Cash & Cash Equivalents	7.66M
Total Debt	7.60M
Net Cash	65,272
Net Cash Per Share	0.05
Equity (Book Value)	40.45M
Book Value Per Share	33.95
Working Capital	14.25M

Cash Flow

In the last 12 months, operating cash flow was 5.84 million and capital expenditures -777,680, giving a free cash flow of 5.06 million.

Operating Cash Flow	5.84M
Capital Expenditures	-777,680
Free Cash Flow	5.06M
FCF Per Share	4.25

Margins

Gross margin is 7.45%, with operating and profit margins of 2.24% and 1.50%.

Gross Margin	7.45%
Operating Margin	2.24%
Pretax Margin	1.76%
Profit Margin	1.50%
EBITDA Margin	3.43%
EBIT Margin	2.24%
FCF Margin	6.51%

Dividends & Yields

LJSE:MKZG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	102.10%
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	15.80%
FCF Yield	68.50%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LJSE:MKZG has an Altman Z-Score of 2 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2
Piotroski F-Score	7